Melinda Arsouze is a U.S. qualified partner specializing in international capital markets. With over ten years of experience in this area, she has advised on numerous major cross-border securities offerings, including block trades, initial public offerings, privatisations, high yield transactions and debt issuances, in the context of public offerings and privately placed transactions in Europe and the United States. A fluent French speaker based primarily in Paris, Melinda works in close coordination with Gide's capital markets teams throughout the international network and has extensive experience in EMEA practice, including in Turkey, North Africa and Asia.
Melinda joined Gide in Paris in 2008 after a number of years at a major U.S. law firm. She is a member of the New York Bar and a graduate of the Columbia University School of Law.
Melinda Arsouze is regularly listed as a leading expert in capital markets by international legal directories Chambers, Legal 500 and IFLR1000.
« Melinda Stege Arsouze is highlighted in particular for her experience in IPOs. She is an expert on US securities law, and her recent work highlights include leading the team in advising GenSight Biologics on its IPO listing on NASDAQ. »
Chambers Global 2017
« Gide Loyrette Nouel produces ‘excellent and efficient work’ and ‘knows very well the standards on the banks’ side and the needs from the issuers’ side’; it has notable experience in mandates involving the public sector. The practice recently assisted the banking syndicate with Vallourec’s €480m capital increase and advised Veolia Environnement on a €700m OCEANE issuance. Arnaud Duhamel ‘shows real judgement in difficult situations rather than sitting on the fence’ and Melinda Stege Arsouze provides US expertise’. »
Legal 500 EMEA 2017
« Gide Loyrette Nouel is ‘one of the few French firms able to compete with the Anglo-Saxon firms’, for issuer and underwriter representations alike. The practice has ‘deep knowledge of French law’ and is also able to provide US law advice including with regard to private placements and US IPOs. The team recently completed a high volume of work in the life sciences sector, notably including advising DBV Technologies SA on its Nasdaq IPO. The practice also assisted the underwriters regarding Solairedirect’s IPO on Euronext Paris and Rule 144A US offering. The team is ‘highly responsive and efficient’. Key figures in the practice include Arnaud Duhamel and Melinda Arsouze, who are both 'very good advisers'. »
Legal 500 EMEA 2016
« US-qualified Melinda Stege Arsouze handles international capital markets matters, with a particular focus on the equity side. »
Chambers Global 2016